PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29475441-0	2018	SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition.	epigallocatechin gallate	68-72	SOX2 overlapping transcript	Homo sapiens	0-6	
29475441-9	2018	RESULTS: We found that EGCG targeting LncRNA SOX2OT variant 7 produced synergistic effects with Doxorubicin on osteosarcoma cell growth inhibition.	epigallocatechin gallate	23-27	SOX2 overlapping transcript	Homo sapiens	45-51	
29475441-10	2018	On the one hand, EGCG could reduce the Doxorubicin-induced pro-survival autophagy through decreasing SOX2OT variant 7 to improve the growth inhibition of Doxorubicin.	epigallocatechin gallate	17-21	SOX2 overlapping transcript	Homo sapiens	101-107	
29475441-11	2018	On the other hand, EGCG could partially inactivate Notch3/DLL3 signaling cascade targeting SOX2OT variant 7 to reduce the stemness then abated drug-resistance of osteosarcoma cells.	epigallocatechin gallate	19-23	SOX2 overlapping transcript	Homo sapiens	91-97